Drug ID: | NPD6213 |
Drug Name: | Amrubicin |
Molecular Formula: | C25H25NO9 |
Canonical SMILES: | O[C@@H]1CO[C@H](C[C@@H]1O)O[C@H]1C[C@@](N)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2)C(=O)C |
Standard InCHI: | InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1 |
Standard InCHIKey: | VJZITPJGSQKZMX-XDPRQOKASA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | |
DrugBank | DB06263 |
ChEMBL | CHEMBL1186894 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | 135779 |
CAS Number | 110267-81-7 |
Molecular Weight | 483.15 |
ALogP | -3.6843 |
MLogP | 3.11 |
XLogP | -0.665 |
HDA | 8 |
HBD | 5 |
Rotatable Bonds | 9 |
TPSA | 176.61 |
RO5 Violation | 0 |